Welcome to McKay Orthopaedic Research Laboratory

A program in orthopaedic research at the University of Pennsylvania was established in 1960, and in 1979 the McKay Orthopaedic Research Laboratory officially opened, establishing all of the orthopaedic research laboratories in the same physical location. Currently, the McKay Lab is a thriving, multidisciplinary facility that occupies more than 22,000 square feet of space in Stemmler Hall in the Perelman School of Medicine. Our multi-faceted research programs involve the participation of more than 120 research personnel from 13 distinct laboratories. Research expenditures in McKay total more than $15,000,000 per annum, supported largely through extramural funding including grants from the National Institutes of Health, Veteran's Administration, other governmental agencies, private foundations, and industry. We are consistently ranked in the top 5 among Orthopaedic Departments nationally in terms of NIH funding. Our overall mission is to conduct high quality fundamental and translational research and to train the next generation of leaders in our field. Moreover, the McKay Lab serves as the focal point for the NIH-supported Penn Center for Musculoskeletal Disorders, a university-wide Center that provides resources and a forum for scientific exchange through annual symposia, a year-long seminar series, a pilot grant program and other activities. 

Read More

McKay Laboratory News

In the News from Qin's Lab: Potential Cellular Target for Eliminating Bone Breakdown in Osteoporosis Found
November 25, 2020
Qin Laboratory

Congratulations to Leilei Zhong!
November 25, 2020
Leilei's abstract, Transient Expansion and Myofibroblast Conversion of Marrow Adipogenic Lineage Precursors (MALPs) Mediate Bone Marrow Repair After Radiation, has been chosen for a PODIUM presentation and POSTER presentation at the ORS 2021 Annual Meeting as a New Investigator Recognition Award (NIRA) finalist.
Qin Laboratory

Congratulations to Tao Gui!
November 24, 2020
Tao's abstract, Targeting Cartilage EGFR Pathway for Osteoarthritis Treatment, has been chosen for a PODIUM presentation at the ORS 2021 Annual Meeting.
Qin Laboratory

More News

Back to Top